Sun’s Ilumya Gnaws At US Psoriasis Market

 
• By Anju Ghangurde

Around 800 physicians have prescribed Sun’s Ilumya, giving it some early traction in the competitive US psoriasis market. The Indian firm is striving to push harder and will also take a call on pursuing additional indications for the product.

Psoriasis
SUN'S ILUMYA HAS MADE INROADS INTO THE PSORIASIS MARKET

More from Business

More from Scrip